Public postsecondary institutions required to maintain a supply of opiate antagonists on system campuses.
Summary
HF862 requires Minnesota public postsecondary institutions to keep opiate antagonists, such as naloxone, available on campus. The Minnesota State Colleges and Universities Board of Trustees would be required to maintain a supply at each campus site, and the University of Minnesota Board of Regents is requested to do the same. The bill also requires at least two doses of a nasal opiate antagonist to be available in each campus residential building. The requirement would begin with the 2025-2026 academic year.
The bill also directs the commissioner of health to identify implementation resources for colleges and universities, including at least one training video, to support emergency response planning for opiate overdose incidents. In addition, the governing boards may adopt a model plan for the use, storage, and administration of opiate antagonists on campuses. The bill amends existing law governing who may administer opiate antagonists by expressly including personnel employed by or under contract with postsecondary institutions, while preserving existing authority for naloxone possession and administration under current law.
Impact
HF862 would add a new section to Minnesota Statutes chapter 135A and amend section 151.37, subdivision 12. It would impose a campus-level preparedness requirement on public postsecondary institutions, especially Minnesota State campuses and, by request, the University of Minnesota, to stock opiate antagonists and ensure availability in residence halls. The bill would also expand the list of authorized personnel who may administer these medications under a physician, physician assistant, or advanced practice registered nurse’s standing order or protocol, reinforcing overdose response authority for college and university staff.
Sentiment
The available record suggests generally supportive sentiment, with the bill advancing from the House Higher Education Finance and Policy Committee and then being re-referred to the Health Finance and Policy Committee. No vote totals or committee testimony are provided, but the bill’s focus on overdose preparedness, campus safety, and access to naloxone indicates a public health-oriented approach that is likely to draw broad support. The absence of recorded opposition or amendments in the provided materials limits the ability to identify a strong negative reaction.
Contention
The main policy questions appear to be implementation-related rather than ideological: whether public colleges and universities should be mandated to maintain supplies on every campus site, how many doses should be required in residential buildings, and how the costs and logistics of storage, training, and replacement will be handled. Another point of potential contention is the bill’s treatment of the University of Minnesota, which is “requested” rather than required to comply, reflecting its distinct governance structure. The amendment to administration authority may also raise questions about training standards and liability, although the bill preserves the requirement for standing orders or protocols and overdose-response training.